← Mechanisms of action
CCR5
SINGLE PROTEINHomo sapiens
Preferred name: C-C chemokine receptor type 5 ChEMBL ↗
Linked proteins
Drugs acting on this target (18)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| adaptavir | Antagonist | experimental | Small molecule | CCR5 antagonist |
| aplaviroc | Antagonist | experimental | Small molecule | CCR5 antagonist |
| azd-5672 | Antagonist | experimental | Small molecule | CCR5 antagonist |
| bms-813160 | Antagonist | experimental | Small molecule | CCR5 antagonist |
| cenicriviroc | Antagonist | experimental | Small molecule | CCR5 antagonist |
| incb-9471 | Antagonist | experimental | Small molecule | CCR5 antagonist |
| maraviroc (selzentry) | Antagonist | approved | Small molecule | CCR5 antagonist |
| ob-002 | Antagonist | experimental | Small molecule | CCR5 antagonist |
| pf-00232798 | Antagonist | experimental | Small molecule | CCR5 antagonist |
| pf-04634817 | Antagonist | experimental | Small molecule | CCR5 antagonist |
| pro-140 monoclonal antibody | Antagonist | experimental | mAb | CCR5 antagonist |
| vicriviroc | Antagonist | experimental | Small molecule | CCR5 antagonist |
| ccr5mab004 | Inhibitor | experimental | mAb | CCR5 inhibitor |
| hgs-1025 | Inhibitor | experimental | mAb | CCR5 inhibitor |
| leronlimab | Inhibitor | experimental | mAb | CCR5 inhibitor |
| pro-140 monoclonal antibody | Inhibitor | experimental | mAb | CCR5 inhibitor |
| rap103 | Inhibitor | experimental | Peptide | CCR5 inhibitor |
| sb-728mr-t | Modulator | experimental | Gene therapy | CCR5 modulator |